FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Sep 10, 2021
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on September 10, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood, Inc.
- Inspection Date
- September 10, 2021
- Product Type
- Biologics
View Company Profile
ID · 5470c369-991f-4d68-93b8-411f1251f079
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1153150
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 11, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 12, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 6, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1232510 - 2024-04-11
- FDA Inspection 1084405 - 2019-02-28
- FDA Inspection 995163 - 2016-12-12
- FDA Inspection 914183 - 2015-02-13
- FDA Inspection 843340 - 2013-08-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.